Thyroid nodule screening: Difference between revisions
No edit summary |
|||
| Line 8: | Line 8: | ||
According to the USPSTF, there is insufficient evidence to recommend routine screening for thyroid nodule. | According to the USPSTF, there is insufficient evidence to recommend routine screening for thyroid nodule. | ||
In Japan’s Fukushima Prefecture, a new intensive screening program was adopted in 2014 for children and adolescents group, in response to the 2011 nuclear accident. The result showed an approxiamtely 30 times thyroid-cancer incidence as high as the national average among the screened children and adolescents. | |||
==References== | ==References== | ||
Revision as of 18:03, 15 August 2017
|
Thyroid nodule Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thyroid nodule screening On the Web |
|
American Roentgen Ray Society Images of Thyroid nodule screening |
|
Risk calculators and risk factors for Thyroid nodule screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
According to USPSTF, screening for thyroid cancer is not recommended and there is insufficient evidence to recommend routine screening for thyroid nodule.[1]
Screening
According to USPSTF, screening for thyroid cancer is not recommended.[1]
According to the USPSTF, there is insufficient evidence to recommend routine screening for thyroid nodule.
In Japan’s Fukushima Prefecture, a new intensive screening program was adopted in 2014 for children and adolescents group, in response to the 2011 nuclear accident. The result showed an approxiamtely 30 times thyroid-cancer incidence as high as the national average among the screened children and adolescents.